Literature DB >> 11483774

Structure-based mutational analysis of the hepatitis C virus NS3 helicase.

C L Tai1, W C Pan, S H Liaw, U C Yang, L H Hwang, D S Chen.   

Abstract

The carboxyl terminus of the hepatitis C virus (HCV) nonstructural protein 3 (NS3) possesses ATP-dependent RNA helicase activity. Based on the conserved sequence motifs and the crystal structures of the helicase domain, 17 mutants of the HCV NS3 helicase were generated. The ATP hydrolysis, RNA binding, and RNA unwinding activities of the mutant proteins were examined in vitro to determine the functional role of the mutated residues. The data revealed that Lys-210 in the Walker A motif and Asp-290, Glu-291, and His-293 in the Walker B motif were crucial to ATPase activity and that Thr-322 and Thr-324 in motif III and Arg-461 in motif VI significantly influenced ATPase activity. When the pairing between His-293 and Gln-460, referred to as gatekeepers, was replaced with the Asp-293/His-460 pair, which makes the NS3 helicase more like the DEAD helicase subgroup, ATPase activity was not restored. It thus indicated that the whole microenvironment surrounding the gatekeepers, rather than the residues per se, was important to the enzymatic activities. Arg-461 and Trp-501 are important residues for RNA binding, while Val-432 may only play a coadjutant role. The data demonstrated that RNA helicase activity was possibly abolished by the loss of ATPase activity or by reduced RNA binding activity. Nevertheless, a low threshold level of ATPase activity was found sufficient for helicase activity. Results in this study provide a valuable reference for efforts under way to develop anti-HCV therapeutic drugs targeting NS3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483774      PMCID: PMC115073          DOI: 10.1128/jvi.75.17.8289-8297.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

Review 1.  D-E-A-D protein family of putative RNA helicases.

Authors:  S R Schmid; P Linder
Journal:  Mol Microbiol       Date:  1992-02       Impact factor: 3.501

2.  A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

Authors:  S Brillanti; J Garson; M Foli; K Whitby; R Deaville; C Masci; M Miglioli; L Barbara
Journal:  Gastroenterology       Date:  1994-09       Impact factor: 22.682

3.  Direct and specific photochemical cross-linking of adenosine 5'-triphosphate to an aminoacyl-tRNA synthetase.

Authors:  V T Yue; P R Schimmel
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

4.  The QRxGRxGRxxxG motif of the vaccinia virus DExH box RNA helicase NPH-II is required for ATP hydrolysis and RNA unwinding but not for RNA binding.

Authors:  C H Gross; S Shuman
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Site-directed mutagenesis of a conserved domain in vaccinia virus thymidine kinase. Evidence for a potential role in magnesium binding.

Authors:  M E Black; D E Hruby
Journal:  J Biol Chem       Date:  1992-04-05       Impact factor: 5.157

6.  Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding.

Authors:  J L Kim; K A Morgenstern; J P Griffith; M D Dwyer; J A Thomson; M A Murcko; C Lin; P R Caron
Journal:  Structure       Date:  1998-01-15       Impact factor: 5.006

7.  Structure-based mutagenesis study of hepatitis C virus NS3 helicase.

Authors:  C Lin; J L Kim
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

8.  Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes.

Authors:  J A Suzich; J K Tamura; F Palmer-Hill; P Warrener; A Grakoui; C M Rice; S M Feinstone; M S Collett
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Clinical outcomes after transfusion-associated hepatitis C.

Authors:  M J Tong; N S el-Farra; A R Reikes; R L Co
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

10.  Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes.

Authors:  A E Gorbalenya; E V Koonin; A P Donchenko; V M Blinov
Journal:  Nucleic Acids Res       Date:  1989-06-26       Impact factor: 16.971

View more
  34 in total

1.  Coordinate replication of alfalfa mosaic virus RNAs 1 and 2 involves cis- and trans-acting functions of the encoded helicase-like and polymerase-like domains.

Authors:  A Corina Vlot; Sebastiaan M Laros; John F Bol
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 2.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

Review 3.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

4.  Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism.

Authors:  Meigang Gu; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-31       Impact factor: 11.205

5.  Agrobacterium rhizogenes GALLS protein contains domains for ATP binding, nuclear localization, and type IV secretion.

Authors:  Larry D Hodges; Annette C Vergunst; Jason Neal-McKinney; Amke den Dulk-Ras; Deborah M Moyer; Paul J J Hooykaas; Walt Ream
Journal:  J Bacteriol       Date:  2006-09-29       Impact factor: 3.490

6.  Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.

Authors:  Sergey A Shiryaev; Igor A Kozlov; Boris I Ratnikov; Jeffrey W Smith; Michal Lebl; Alex Y Strongin
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

7.  Motif V regulates energy transduction between the flavivirus NS3 ATPase and RNA-binding cleft.

Authors:  Kelly E Du Pont; Russell B Davidson; Martin McCullagh; Brian J Geiss
Journal:  J Biol Chem       Date:  2019-12-30       Impact factor: 5.157

8.  Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone.

Authors:  Partha K Chandra; Sidhartha Hazari; Bret Poat; Feyza Gunduz; Ramesh Prabhu; Gerald Liu; Roberto Burioni; Massimo Clementi; Robert F Garry; Srikanta Dash
Journal:  Virol J       Date:  2010-06-07       Impact factor: 4.099

9.  Electrostatic analysis of the hepatitis C virus NS3 helicase reveals both active and allosteric site locations.

Authors:  David N Frick; Ryan S Rypma; Angela M I Lam; Christopher M Frenz
Journal:  Nucleic Acids Res       Date:  2004-10-12       Impact factor: 16.971

10.  Two novel conserved motifs in the hepatitis C virus NS3 protein critical for helicase action.

Authors:  Angela M I Lam; David Keeney; David N Frick
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.